These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 30306626

  • 1. SPG11-related parkinsonism: Clinical profile, molecular imaging and l-dopa response.
    Faber I, Martinez ARM, Martins CR, Maia ML, Souza JP, Lourenço CM, Marques W, Montecchiani C, Orlacchio A, Pedroso JL, Barsottini OGP, Ramos CD, Lopes-Cendes Í, Friedman JH, Amorim BJ, França MC.
    Mov Disord; 2018 Oct; 33(10):1650-1656. PubMed ID: 30306626
    [Abstract] [Full Text] [Related]

  • 2. SPG7 with parkinsonism responsive to levodopa and dopaminergic deficit.
    Pedroso JL, Vale TC, Bueno FL, Marussi VHR, Amaral LLFD, França MC, Barsottini OG.
    Parkinsonism Relat Disord; 2018 Feb; 47():88-90. PubMed ID: 29246844
    [Abstract] [Full Text] [Related]

  • 3. Striatal dopaminergic functioning in patients with sporadic and hereditary spastic paraplegias with parkinsonism.
    Kim JS, Kim JM, Kim YK, Kim SE, Yun JY, Jeon BS.
    J Korean Med Sci; 2013 Nov; 28(11):1661-6. PubMed ID: 24265532
    [Abstract] [Full Text] [Related]

  • 4. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
    Tinazzi M, Morgante F, Matinella A, Bovi T, Cannas A, Solla P, Marrosu F, Nicoletti A, Zappia M, Luca A, Di Stefano A, Morgante L, Pacchetti C, Minafra B, Sciarretta M, Dallocchio C, Rossi S, Ulivelli M, Ceravolo R, Frosini D, Cipriani A, Barbui C.
    Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
    [Abstract] [Full Text] [Related]

  • 5. Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levodopa-responsive Parkinsonism.
    Guidubaldi A, Piano C, Santorelli FM, Silvestri G, Petracca M, Tessa A, Bentivoglio AR.
    Mov Disord; 2011 Feb 15; 26(3):553-6. PubMed ID: 21381113
    [Abstract] [Full Text] [Related]

  • 6. Parkinsonism without dopamine neuron degeneration in aged l-dopa-responsive dystonia knockin mice.
    Rose SJ, Harrast P, Donsante C, Fan X, Joers V, Tansey MG, Jinnah HA, Hess EJ.
    Mov Disord; 2017 Dec 15; 32(12):1694-1700. PubMed ID: 28949038
    [Abstract] [Full Text] [Related]

  • 7. Novel compound heterozygous synaptojanin-1 mutation causes l-dopa-responsive dystonia-parkinsonism syndrome.
    Rauschendorf MA, Jost M, Stock F, Zimmer A, Rösler B, Rijntjes M, Piroth T, Coenen VA, Reinacher PC, Meyer PT, Frings L, Weiller C, Fischer J, Klebe S.
    Mov Disord; 2017 Mar 15; 32(3):478-480. PubMed ID: 27869329
    [No Abstract] [Full Text] [Related]

  • 8. Clinical and [99mTc]TRODAT-1/[123I]IBZM SPECT imaging findings in dopa-responsive dystonia.
    Hwang WJ, Yao WJ, Wey SP, Ting G.
    Eur Neurol; 2004 Mar 15; 51(1):26-9. PubMed ID: 14631126
    [Abstract] [Full Text] [Related]

  • 9. Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome.
    Hesse S, Oehlwein C, Barthel H, Schwarz J, Polster D, Wagner A, Sabri O.
    J Neural Transm (Vienna); 2006 Sep 15; 113(9):1177-90. PubMed ID: 16463120
    [Abstract] [Full Text] [Related]

  • 10. HIV-associated Parkinsonism with levodopa-induced dyskinesia and response to highly-active antiretroviral therapy.
    Kobylecki C, Silverdale MA, Varma A, Dick JP, Kellett MW.
    Mov Disord; 2009 Dec 15; 24(16):2441-2. PubMed ID: 19908326
    [No Abstract] [Full Text] [Related]

  • 11. The relationship between cerebral vascular disease and parkinsonism: The VADO study.
    Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP.
    Parkinsonism Relat Disord; 2012 Jul 15; 18(6):775-80. PubMed ID: 22531611
    [Abstract] [Full Text] [Related]

  • 12. Dopamine transporter imaging in clinically unclear cases of parkinsonism and the importance of scans without evidence of dopaminergic deficit (SWEDDs).
    Utiumi MA, Felício AC, Borges CR, Braatz VL, Rezende SA, Munhoz RP, Bressan RA, Ferraz HB, Teive HA.
    Arq Neuropsiquiatr; 2012 Sep 15; 70(9):667-73. PubMed ID: 22990721
    [Abstract] [Full Text] [Related]

  • 13. Reproducibility of brain dopamine transporter binding with Tc-99m TRODAT-1 SPECT in healthy young men.
    Yeh CB, Chou YH, Cheng CY, Lee MS, Wang JJ, Lee CH, Shiue CY, Su TP, Huang WS.
    Psychiatry Res; 2012 Mar 31; 201(3):222-5. PubMed ID: 22551783
    [Abstract] [Full Text] [Related]

  • 14. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS, Jeong JM, Park SS, Kim JM, Chang YS, Song HC, Kim KM, Yoon KY, Lee MC, Lee SB.
    Ann Neurol; 1998 Jun 31; 43(6):792-800. PubMed ID: 9629849
    [Abstract] [Full Text] [Related]

  • 15. Clinical and genetic evaluation of 8 Polish families with levodopa-responsive parkinsonism.
    Krygowska-Wajs A, Kachergus JM, Hulihan MM, Farrer MJ, Searcy JA, Booij J, Berendse HW, Wolters ECh, Wszolek ZK.
    J Neural Transm (Vienna); 2005 Nov 31; 112(11):1487-502. PubMed ID: 15785861
    [Abstract] [Full Text] [Related]

  • 16. Beta-CIT-SPECT combined with UPDRS appears to distinguish different parkinsonian conditions.
    Sjøholm H, Sundsfjord J, Mellgren SI.
    Acta Neurol Scand; 2002 Jan 31; 105(1):5-7. PubMed ID: 11903101
    [Abstract] [Full Text] [Related]

  • 17. Dopaminergic neuronal integrity in parkinsonism associated with liver cirrhosis.
    Kim JM, Kim JS, Jeong SH, Kim YK, Kim SE, Kim SH, Kim Y.
    Neurotoxicology; 2010 Aug 31; 31(4):351-5. PubMed ID: 20457180
    [Abstract] [Full Text] [Related]

  • 18. Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2.
    Lu CS, Wu Chou YH, Yen TC, Tsai CH, Chen RS, Chang HC.
    Mov Disord; 2002 Sep 31; 17(5):1046-51. PubMed ID: 12360557
    [Abstract] [Full Text] [Related]

  • 19. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.
    Parkinson Study Group.
    JAMA; 2002 Apr 03; 287(13):1653-61. PubMed ID: 11926889
    [Abstract] [Full Text] [Related]

  • 20. SPG11 spastic paraplegia. A new cause of juvenile parkinsonism.
    Anheim M, Lagier-Tourenne C, Stevanin G, Fleury M, Durr A, Namer IJ, Denora P, Brice A, Mandel JL, Koenig M, Tranchant C.
    J Neurol; 2009 Jan 03; 256(1):104-8. PubMed ID: 19224311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.